Evotec (EVO) joins

Photo of author

By [email protected]


EvOTEC SE (NASDAQ:Evo) He is One of the 10 best shares of health care for purchase, according to analysts. On June 25, the company said it will participate in the porridge of Aki, to investigate an acute kidney injury (AKI) and develop drug detection through multi -OPEC approaches.

Evotec (EVO) joins
Evotec (EVO) joins

A research team in laboratory coats tests a new immune platform in the modern biotechnology laboratory.

AKI is to create the world’s largest database for AKI with two parts of two parts: to enhance the understanding of its molecular mechanisms and accelerate the discovery of drugs. The Federation is supported by 4.7 million pounds of industry partners, including EvOTEC and Astrazneca (Nasdaq: azn) and Nephrollyx GmbH, which is easy to do. Professor Nick Silby, the main researcher, supervises AKI research efforts in the upbringing initiative.

Besides helping to finance the consortium, EvOTEC will merge the union data on its E.MPD platform. The company will also make modern omics analyzes to determine the basic biological mechanisms, molecular goals and vital signs of AKI. Ultimately, the EvOTEC partnership managed to discover the target medicines by taking advantage of molecular visions in the development of AKI.

EVOTEC SE (NASDAQ: EVO) is a German vital technical company. It works as a partner to discover and develop medicines for biomedical and biotechnology companies around the world. The two main seizures are research and development, which provides integrated research services and fair EvOTEC biology, which provides biology development and manufacturing.

While we acknowledge the poto capabilities as an investment, we believe that some artificial intelligence shares provide greater potential in the upward trend and carry less risks on the downside. If you are looking for a stock of artificial intelligence with less than very apprecia The best inventory of artificial intelligence in the short term.

Read the following: Power stocks in Goldman Sachs: 10 shares for purchase and 10 best shares of Amnesty International for purchase, according to billionaire David.

Detection: Nothing.



https://s.yimg.com/ny/api/res/1.2/_5dnyO9thktkk8u_5Ne8Gw–/YXBwaWQ9aGlnaGxhbmRlcjt3PTEyMDA7aD02NzM-/https://media.zenfs.com/en/insidermonkey.com/89f6be1da850b22042e3702894fcf9bf

Source link

Leave a Comment